Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 27, 2022
How agarose gels surrounding PLGA implants limit swelling and slow down drug releaseC Bassand, J Verin, M Lamatsch, et al.International Journal of Pharmaceutics|December 3, 2014
How to easily provide zero order release of freely soluble drugs from coated pelletsB Dekyndt, J Verin, C Neut, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 6, 2022
PLGA implants for controlled drug release: Impact of the diameterC Bassand, J Freitag, L Benabed, et al.International Journal of Pharmaceutics: X|October 3, 2022
How bulk fluid renewal can affect in vitro drug release from PLGA implants: Importance of the experimental set-upC Bassand, L Benabed, J Freitag, et al.International Journal of Pharmaceutics: X|February 21, 2024
Colon targeting in rats, dogs and IBD patients with species-independent film coatingsF Ferraro, L M Sonnleitner, C Neut, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 4, 2018
Hybrid Ear Cubes for local controlled dexamethasone delivery to the inner earM Gehrke, J Verin, D Gnansia, et al.International Journal of Pharmaceutics|August 21, 2016
Towards a better understanding of the different release phases from PLGA microparticles: Dexamethasone-loaded systemsH Gasmi, F Siepmann, M C Hamoudi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 4, 2022
3D printed PLGA implants: APF DDM vs. FDMC Bassand, L Benabed, S Charlon, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 15, 2023
3D printed PLGA implants: How the filling density affects drug releaseC Bassand, F Siepmann, L Benabed, et al.Journal of Receptor Research|January 1, 1991
Biologically active monoiodinated alpha-MSH derivatives for receptor binding studies using human melanoma cellsA N Eberle, V J Verin, F Solca, et al.Pageof 2